Double hit to malaria from new drug candidate
New antimalarial compounds target two molecules involved in critical stages of the parasite’s life cycle, finds new research including University of Melbourne.
From decades to days: 3D modelling tuberculosis
3D modelling of TB mutations means doctors could soon tailor individual treatments for the disease in days, not years, say University of Melbourne researchers.
Trapping malaria in a gene net
Malaria’s ability to mutate to nullify drugs is actually its downfall, delivering a new weapon for stopping the spread of resistance.
The new battlefront in malaria research
An international research team is working to combat emerging resistance to antimalarials, within a limited timeline and budget.